A voluntary environmental classification system for pharmaceutical substances

Drug Information Journal

Volumn 41, Issue 2, 2007, Pages 187-191

  Mattson, Bengt ^a  

^a PFIZER INC   (United States)

Author keywords

Bioaccumulation; Environmental risk assessments; Exotoxicology; Persistence; Pharmaceuticals in the environment

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; DRUG; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE;

BIOACCUMULATION; CONFERENCE PAPER; DRUG CLASSIFICATION; DRUG DEGRADATION; DRUG INDUSTRY; DRUG INFORMATION; ENVIRONMENTAL IMPACT; ENVIRONMENTAL SANITATION; POLLUTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 33947206570     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150704100209     Document Type: Conference Paper

References (4)

1. Medical Products Agency. Environmental Impact From Pharmaceuticals as Well as Cosmetics and Hygienic Articles [in Swedish]. Report from the Swedish MPA; August 2004; Uppsala.
2. Carlsson C, Johansson A-K, Alvan G, et al. Are pharmaceuticals potent environmental pollutants? I: environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ. 2006;364:67-87.
3. Carlsson C, Johansson A-K, Alvan G et al. Are pharmaceuticals potent environmental pollutants? II: environmental risk assessments of selected pharmaceutical excipients. Sci Total Environ. 2006;364:88-95.
4. Swedish Association of the Pharmaceutical Industry. Guidance document for companies. Available at: http://www.fass.se/LIF/produktfakta/ fakta_lakare_artikel_jsp?articleID=76074. Accessed October 4, 2006.